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Fe(OTf)3Abstract A series of chromeno[2,3-b]quinolinol derivatives were synthesized through one-pot
four-component reaction of resorcinol, malononitrile, aromatic aldehydes and cyclohexanone using
iron(III) triﬂate Fe(OTf)3, under solvent-free and ultrasonic irradiation conditions. The products
were afforded in good to excellent yields. The advantages of this method are the use of an inexpen-
sive and readily available catalyst, short reaction time, easy workup and improved yields.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Chromenoquinolinol compounds are well-known and an
important class of heterocyclic compounds due to their var-
ious biological activities such as anti-inﬂammatory and
estrogenic (Munoz et al., 1982; Yamada et al., 1992; Lee
et al., 2004). Especially, chromenoquinolin derivatives exhi-
bit cancer chemopreventive (Azuine et al., 2004), and activ-
ities including anti-tubercular (Srivastava et al., 2005),
antimyopic, hypotensive (Goto et al., 1984), anti-rheumatic
(Maruyama et al., 1981) and antiasthmatic activities (Ukawa
et al., 1985).
Tow step synthesis of chromeno[2,3-b]quinolin-3-ol deriva-
tives has been reported recently (Raghuvanshi and Singh,2010). Synthesis of 4-[(N-Imidazol-2-ylmethyl)anilino]pyrano-
pyridine derivatives and 2-aryl-4H-pyrano[2,3-b]pyridin-4-
ones has been reported (Sunkyung et al., 2005; Khlebinkov
et al., 2009). However, due to the economical and atom efﬁ-
ciency issues, the development of a one-pot, efﬁcient, rapid
and convenient protocol for the synthesis of chromenoquino-
linol (pyranopyridines) is still of remarkable interest.
Ultrasound has been increasingly employed in organic syn-
thesis in the last three decades. It has been demonstrated as an
alternative energy source for organic reactions ordinarily
accomplishedbyheating.Theuse of ultrasound irradiation tech-
nique for activating various reactions is well documented in the
literature (Singh et al., 2003; Li et al., 2002; Robin et al., 2002).
As a part of our research to develop novel MCRs using
efﬁcient and heterogeneous catalysts (Damavandi 2011;
Damavandi and Sandaroos, 2011), herein, one-potsynthesis
of various 11-amino-12-(4-aryl)-8,9,10,12-tetrahydro-7H-chro-
meno[2,3-b]quinolin-3-ol derivatives via four-component
reaction of resorcinol, malononitrile, aromatic aldehydes and
cyclohexanone using the catalytic system of Fe(OTf)3/ultra-
sonic irradiation (see Scheme 1).
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2.1. Materials and methods
Chemicals were either prepared in our laboratories or pur-
chased from Merck, Fluka and Aldrich Chemical Companies.
All yields refer to isolated products. IR spectra were recorded
on a Shimadzu-IR 470 spectrophotometer. 1H NMR spectra
was recorded on a Bruker 100-MHz spectrometer in chloro-
form as the solvent and TMS as the internal standard. Flash
column chromatography was performed with 300 and 400
meshes silica gel and analytical thin layer chromatography
was performed on pre-coated silica gel plates (60F-254). Soni-
cation was performed in a Shanghai Branson-CQX ultrasonic
cleaner with a frequency of 40 kHz and a nominal power of
100 W. Elemental analyzes were performed on Thermo Finni-
gan EA1112 elemental analyzer.
2.2. General procedure for synthesis of pyrano[2,3-b]pyridine
derivatives
In a round bottom ﬂask a mixture of resorcinol (1 mmol), mal-
ononitrile (1.1 mmol), aromatic aldehyde (1 mmol) and cyclo-
hexanone (1 mmol) was mixed with iron triﬂate (0.1 mmol)
and the mixture was irradiated under ultrasonic waves at room
temperature for an appropriate time as indicated in Table 1.
The progress of the reaction was monitored by TLC (ethyl ace-
tate:n-hexane, 1:5). Upon completion of the reaction, the mix-
ture was extracted with AcOEt (3 · 10 ml) and washed with
aq. NaHCO3 solution. Then the organic phase was dried over
MgSO4 and concentrated under reduced pressure. The crude
product was chromatographed on silica gel eluting with
n-hexane-AcOEt (5:1). Spectral data for the products are as
follows.
2.2.1. 11-amino-8,9,10,12-tetrahydro-12-phenyl-7H-
chromeno[2,3-b]quinolin-3-ol (entry 1)
Temperature 311–312 C [(313–315 C) (Raghuvanshi and
Singh, 2010)], IR (KBr): 3440, 3365, 3018, 1614, 1527, 1238,
1111 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.60 (m,
4H, CH2), 2.30 (m, 2H, CH2), 2.62 (m, 2H, CH2), 5.33 (s,
1H, CH), 6.75–7.45 (m, 10H, ArH, NH2), 9.60 (s, 1H, OH).
Anal. Calcd for C22H20N2O2: C, 76.72; H, 5.85; N, 8.13.
Found: C, 75.66; H, 5.99; N, 7.95.
2.2.2. 11-amino-12-(4-bromophenyl)-8,9,10,12-tetrahydro-
7H-chromeno[2,3-b]quinolin-3-ol (entry 2)
The mp: 283–285 C [(280–282 C) (Raghuvanshi and Singh,
2010)], IR (KBr): 3434, 3376, 2977, 1607, 1488, 1206,
1167 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.64 (m,
4H, CH2), 2.28 (m, 2H, CH2), 2.55 (m, 2H, CH2), 5.40 (s,
1H, CH), 6.35 (br, 2H, NH2), 6.65–7.40 (m, 7H, ArH), 9.80Scheme 1 One-pot synthesis of 11-amino-12-(4-aryl)-8,(s, 1H, OH). Anal. Calcd for C22H19BrN2O2: C, 62.42; H,
4.52; N, 6.62. Found: C, 62.17; H, 4.44; N, 6.73.
2.2.3. 11-amino-12-(4-chlorophenyl)-8,9,10,12-tetrahydro-
7H-chromeno[2,3-b]quinolin-3-ol (entry 3)
The mp: 290–292 C, IR (KBr): 3422, 3150, 2885, 1624, 1448,
1233 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.55 (m, 4H,
CH2), 2.45 (m, 2H, CH2), 2.64 (m, 2H, CH2), 5.65 (s, 1H, CH),
6.15 (br, 2H, NH2), 6.72–7.42 (m, 7H, ArH), 10.10 (s, 1H,
OH). Anal. Calcd for C22H19ClN2O2: C, 69.75; H, 5.05; N,
7.39; Found: C, 69.22; H, 4.97; N, 7.32.
2.2.4. 11-amino-8,9,10,12-tetrahydro-12-(4-methoxyphenyl)-
7H-chromeno[2,3-b]quinolin-3-ol (entry 4)
The mp: 295–297 C [(295–297 C) (Raghuvanshi and Singh,
2010)], IR (KBr): 3475, 3388, 2907, 1619, 1455, 1223,
1166 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.55 (m,
4H, CH2), 2.25 (m, 2H, CH2), 2.40 (m, 2H, CH2), 3.75 (s,
3H, OCH3), 5.55 (s, 1H, CH), 6.25 (s, 2H, NH2), 6.6–7.4 (m,
7H, ArH), 9.75 (s, 1H, OH). Anal. Calcd for C23H22N2O3:
C, 73.78; H, 5.92; N, 7.48. Found: C, 73.52; H, 5.80; N, 7.34.
2.2.5. 11-amino-8,9,10,12-tetrahydro-12-p-tolyl-7H-
chromeno[2,3-b]quinolin-3-ol (entry 5)
The mp: 284–286 C [(282–284 C) (Raghuvanshi and Singh,
2010)], IR (KBr): 3455, 3365, 2910, 1613, 1433, 1218,
1165 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.60 (m,
4H, CH2), 2.20 (s, 3H, CH3), 2.35 (m, 2H, CH2), 2.55 (m,
2H, CH2), 5.40 (s, 1H, CH), 6.10 (s, 2H, NH2), 6.45–7.20
(m, 7H, ArH), 9.63 (s, 1H, OH). Anal. Calcd for
C23H22N2O2: C, 77.07; H, 6.19; N, 7.82. Found: C, 76.73; H,
6.30; N, 7.71.
2.2.6. 11-amino-8,9,10,12-tetrahydro-12-(3,4,5-
trimethoxyphenyl)-7H-chromeno[2,3-b]quinolin-3-ol (entry 6)
The mp: 275–277 C [(285–287 C) (Raghuvanshi and Singh,
2010)], IR (KBr): 3444, 3370, 2895, 1635, 1425, 1211,
1105 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.75 (m,
4H, CH2), 2.40 (m, 2H, CH2), 2.57 (m, 2H, CH2), 3.60 (s,
3H, OCH3), 3.65 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 5.14
(s, 1H, CH), 6.35 (s, 2H, NH2), 6.60–7.10 (m, 5H, ArH),
9.70 (s, 1H, OH). Anal. Calcd for C25H26N2O5: C, 69.11; H,
6.03; N, 6.45. Found: C, 68.74; H, 5.90; N, 6.34.
2.2.7. 11-amino-12-(4-(dimethylamino)phenyl)-8,9,10,12-
tetrahydro-7H-chromeno[2,3-b]quinolin-3-ol (entry 7)
The mp: 310–312 [>320 C (Raghuvanshi and Singh, 2010)].
IR (KBr): 3472, 3384, 2910, 1638, 1447, 1221, 1155 cm1. 1H
NMR (100 MHz, DMSO-d6): d= 1.72 (m, 4H, CH2), 2.2–
2.70 (m, 4H, CH2), 2.90 (s, 6H, N(CH3)2), 5.25 (s, 1H, CH),
4.85 (brs, 2H, NH2), 6.60–7.10 (m, 7H, ArH), 9.45 (s, 1H,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ol.
Table 1 Results of pyranopyridine derivatives’ synthesis.a
Entry Product Time (min) Isolated yield (%) Entry Product Time (min) Isolated yield (%)
1 35 88 7 40 80
2 32 90 8 34 86
3 35 88 9 30 92
4 40 85 10 50 85
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S944 S. DamavandiOH). Anal. Calcd for C24H25N3O2: C, 74.39; H, 6.50; N, 10.84.
Found: C, 74.11; H, 6.41; N, 10.66.
2.2.8. 11-amino-12-(4-ﬂuorophenyl)-8,9,10,12-tetrahydro-7H-
chromeno[2,3-b]quinolin-3-ol (entry 8)
The mp: 292 C [(292–294 C) (Raghuvanshi and Singh,
2010)], IR (KBr): 3472, 3385, 2885, 1616, 1427, 1266 cm1.
1H NMR (100 MHz, DMSO-d6): d= 1.64 (m, 4H, CH2),
2.35–2.65 (m, 4H, CH2), 5.18 (s, 1H, CH), 6.05 (s, 2H,
NH2), 6.57–7.15 (m, 7H, ArH), 9.50 (s, 1H, OH). Anal. Calcd
for C22H19FN2O2: C, 72.91; H, 5.28; N, 7.73. Found: C, 72.66;
H, 5.17; N, 7.64.
2.2.9. 11-amino-8,9,10,12-tetrahydro-12-(4-nitrophenyl)-7H-
chromeno[2,3-b]quinolin-3-ol (entry 9)
The mp: 322–324. IR (KBr): 3425, 3390, 2865, 1630, 1510,
1435, 1325 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.55
(m, 4H, CH2), 2.30–2.62 (m, 4H, CH2), 5.60 (s, 1H, CH),
6.35 (brs, 2H, NH2), 6.57–7.15 (m, 5H, ArH), 8.05 (m, 2H,
ArH), 10.65 (s, 1H, OH). Anal. Calcd for C22H19N3O4: C,
67.86; H, 4.92; N, 10.79. Found: C, 67.21; H, 5.01; N, 10.86.
2.2.10. 11-amino-8,9,10,12-tetrahydro-12-(4-hydroxyphenyl)-
7H-chromeno[2,3-b]quinolin-3-ol (entry 10)
The mp: >330 C, IR (KBr): 3455, 3410, 3377, 1652, 1468,
1313, 1205 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.60
(m, 4H, CH2), 2.40–2.75 (m, 4H, CH2), 5.55 (s, 1H, CH),
5.70 (brs, 2H, NH2), 6.65–7.05 (m, 7H, ArH), 10.10 (brs,
2H, OH). Anal. Calcd for C22H20N2O3: C, 73.32; H, 5.59; N,
7.77. Found: C, 72.74; H, 5.51; N, 7.68.
2.2.11. 11-amino-12-(furan-2-yl)-8,9,10,12-tetrahydro-7H-
chromeno[2,3-b]quinolin-3-ol (entry 11)
The mp: 314–315 C [(318–320 C) (Raghuvanshi and Singh,
2010)], IR (KBr): 3470, 3392, 2875, 1637, 1449, 1228 cm1.
1H NMR (100 MHz, DMSO-d6): d= 1.73 (m, 4H, CH2),
2.26-2.66 (m, 4H, CH2), 5.22 (s, 1H, CH), 6.44 (brs, 2H,
NH2), 6.70–7.25 (m, 6H, ArH), 9.20 (s, 1H, OH). Anal. Calcd
for C20H18N2O3: C, 71.84; H, 5.43; N, 8.38. Found: C, 71.27;
H, 5.25; N, 8.22.
2.2.12. 11-amino-8,9,10,12-tetrahydro-12-(naphthalen-1-yl)-
7H-chromeno[2,3-b]quinolin-3-ol (entry 12)
The mp: 284–286 C, IR (KBr): 3425, 3385, 2972, 1641, 1443,
1196 cm1. 1H NMR (100 MHz, DMSO-d6): d= 1.55 (m, 4H,
CH2), 2.32 (m, 2H, CH2), 2.61 (m, 2H, CH2), 5.17 (s, 1H, CH),
6.15 (brs, 2H, NH2), 6.85–7.52 (m, 10H, ArH), 9.45 (s, 1H,
OH). Anal. Calcd for C26H22N2O2: C, 79.16; H, 5.62; N,
7.10. Found: C, 78.66; H, 5.74; N, 7.01.
3. Results and discussion
First of all, the one-pot reaction of resorcinol, malononitrile,
nitrobenzaldehydes and cyclohexanone was carried out under
solvent-free and ultrasonic irradiation using iron(III) triﬂate.
The reaction was considered as a standard model reaction.
In order to evaluate the inﬂuence of ultrasonic irradiation, ﬁrst
the model reaction (Table 1, entry 9) was examined without
ultrasonication at room temperature. Not only a moderate
yield of 57% with prolonged reaction time (4 h) was found,
but the byproduct was also isolated. However, when the
Scheme 2 The proposed mechanism.
A novel four-component route to synthesis 11-amino-12-(4-aryl)-8,9,10,12-tetrahydro-7H-chromeno S945reaction was carried out under ultrasonication at room
temperature, the target product of 11-amino-8,9,10,12-tetrahy-
dro-12-(4-nitrophenyl)-7H-chromeno[2,3-b]quinolin-3-ol was
obtained in 88% yield within short reaction time (35 min).
Furthermore, no byproduct was detected when the reaction
was carried out under ultrasonic irradiation.
As shown in Table 1, the scope and generality of this
protocol were illustrated with respect to the various aromatic
aldehydes. Aromatic aldehydes substituted with either elec-
tron-donating or electron-withdrawing groups underwent the
reaction smoothly and gave the corresponding 11-amino-12-
(4-aryl)-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ol
in good to excellent yields. In addition, heterocyclic arylalde-
hyde (furfuraldehyde) was reacted with resorcinol, malononit-
rile in combination with cyclohexanone under the same
experimental conditions, and 11-amino-12-(furan-2-yl)-
8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ol were
obtained in moderate yields (Table 1, entries 11).
The proposed mechanism is depicted in Scheme 2. The
aldehyde is ﬁrst condensed with malononitrile to afford
a-cyanocinnamonitrile by Knoevenagel addition. Resorcinol
C-alkylation gives an intermediate which cyclizes via nucleo-
philic attack of an O atom on the cyano moiety followed by
protonation and rearrangement to produce the intermediate
of 2-amino-3-cyano-7-hydroxy-4-substituted-4H-chromene
which could be isolated to investigate the mechanism. Subse-
quently, cyclohexanone which is activated by the catalyst
reacts with the chromene to furnish the corresponding 11-ami-
no-12-(4-aryl)-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quino-
lin-3-ol derivatives.
4. Conclusion
In summary, a novel, one-pot four-component coupling of res-
orcinol, malononitrile, aromatic aldehydes and cyclohexanone
to synthesis 11-amino-12-(4-aryl)-8,9,10,12-tetrahydro-7H-
chromeno[2,3-b]quinolin-3-ol derivatives using Fe(OTf)3 undersolvent-free conditions using ultrasonic irradiation has been
described. The catalytic system afforded the corresponding
chromeno[2,3-b]quinolin-3-ol derivatives in high to excellent
yields. No undesired side product could be detected and the
four-component reactions proceed efﬁciently at ambient
temperature.
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